Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
51.2% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
23
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
6.7% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
24.6% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
1
users have commented on this narrative
5
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Icade
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Paris Pipeline And ESG Projects Will Fuel Sustainable Prosperity
Key Takeaways Prestigious leases and urban transformation projects could accelerate occupancy and drive sustained, above-expectation revenue and earnings growth. ESG leadership and expansion into student housing and data centers position Icade for premium rents, diversification, and structural outperformance.
View narrative
€36.36
FV
42.3% undervalued
intrinsic discount
16.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Galiano Gold
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Global Gold Demand And ESG Trends Will Reshape Mining Operations
Key Takeaways Ahead-of-schedule mining and richer-than-expected resource discoveries may accelerate revenue growth, increase operating cash flow, and extend mine life. Strong gold price leverage, disciplined financial management, and leading ESG standards position the company to attract capital and drive sustained shareholder value.
View narrative
CA$5.87
FV
50.1% undervalued
intrinsic discount
29.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ME Group International
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Digital ID And Urbanization Will Grow Self-Service Demand
Key Takeaways Sustained growth is driven by new installations, next-gen product launches, and expanding margins through AI, automation, and digital innovation. Regulatory demand and shifting consumer trends bolster recurring revenue, high market share, and enhance site partnerships, supporting long-term profitability and resilience.
View narrative
UK£3.05
FV
33.9% undervalued
intrinsic discount
9.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Kiniksa Pharmaceuticals International
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
ARCALYST Uptake And Pipeline Progress Will Expand Rare Markets
Key Takeaways Strong ARCALYST adoption and patient access improvements could drive revenue and margin growth well beyond current market expectations. Diversified pipeline and digital innovation position Kiniksa for sustained growth and reduced reliance on any single product.
View narrative
US$55.00
FV
39.0% undervalued
intrinsic discount
28.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Akebia Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Growing CKD Prevalence Will Fuel Global Oral Therapy Adoption
Key Takeaways Rapid adoption of Vafseo and streamlined regulatory strategy could significantly expand market reach and drive superior revenue growth domestically and internationally. Strong product performance, cost control, and resilience in legacy products support ongoing R&D investment and improved financial stability.
View narrative
US$10.00
FV
69.1% undervalued
intrinsic discount
22.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
GT
Goodyear Tire & Rubber
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Rising Vehicle Miles And EV Trends Will Boost Premium Tires
Key Takeaways Execution ahead of cost-saving targets and premium product innovation are positioning the company for significant margin and earnings growth beyond current expectations. Strategic manufacturing localization and expansion into EV and digital service segments are supporting sustained market share gains, pricing power, and diversified high-margin revenue streams.
View narrative
US$14.95
FV
43.3% undervalued
intrinsic discount
1.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Aurinia Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Aging Demographics And LUPKYNIS Uptake Will Expand Markets
Key Takeaways Rapidly growing adoption of LUPKYNIS and expanded treatment guidelines are strengthening revenue growth and improving profitability through longer patient use and greater prescriber confidence. Diversified autoimmune pipeline, operational efficiency, and shareholder-friendly capital allocation are positioning Aurinia for superior long-term growth, margin improvement, and increased earnings per share.
View narrative
US$16.46
FV
25.8% undervalued
intrinsic discount
22.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Global-E Online
AN
AnalystHighTarget
Consensus Narrative from 13 Analysts
Digital Payments And Local Retail Trends Will Unlock Cross-Border Potential
Key Takeaways Expansion into digital and hybrid brands, along with regulatory and compliance leadership, positions the company for accelerated merchant growth and higher earnings potential. Deepening partnerships, AI integration, and personalized shopping experiences strengthen competitive advantages, driving higher margins, platform stickiness, and improved long-term profitability.
View narrative
US$64.00
FV
50.1% undervalued
intrinsic discount
26.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Exact Sciences
AN
AnalystHighTarget
Consensus Narrative from 23 Analysts
AI And Genomics Will Expand Screening For Aging Markets
Key Takeaways Faster-than-expected adoption of new products and AI-driven patient engagement may drive earlier and stronger recurring revenue and margin improvements than anticipated. Expansion into multi-cancer detection and blood-based diagnostics, combined with operational efficiencies, positions the company for leadership in diagnostics and sustained higher profitability.
View narrative
US$78.20
FV
41.0% undervalued
intrinsic discount
14.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies